CD44及其在固体癌症中的作用 - - 综述:从瘤进展到预后和向治疗
João Martins Gama1,2, Rui Caetano Oliveira3,4,5
1Serviço de Anatomia Patológica, Centro Hospitalar e Universitário de Coimbra, 3004-561 Coimbra, Portugal.
Frontiers in bioscience (Landmark edition)
|March 28, 2025
概括
分化44集群 (CD44) 是一种在癌症中过度表达的跨膜蛋白,驱动癌症干细胞 (CSC) 的瘤进展和化学抵抗. 向CD44为患者分层和治疗决策提供了有前途的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫组织化学 免疫组织化学
背景情况:
- 分化44集群 (CD44) 是一种跨膜蛋白.
- CD44在正常细胞中表达,但在各种癌症中表达过度.
- CD44在瘤进展和血管生成中起着重要作用.
研究的目的:
- 审查CD44在正常和瘤组织中的特性和表达.
- 讨论CD44在癌症干细胞 (CSC) 和化学抵抗中的作用.
- 探索CD44作为预后标志物和治疗点.
主要方法:
- 文献综述侧重于CD44.4的研究.
- 通过免疫组织化学分析CD44表达的分析.
- 讨论CD44在CSC和治疗策略中的作用.
主要成果:
- CD44的过度表达与瘤进展,组织重塑和血管生成有关.
- CD44是癌症干细胞 (CSC) 的关键标记物,与化学抵抗有关.
- 免疫组织化学是有效的检测CD44过度表达的患者选择.
结论:
- CD44是显著的预后标志物,也是癌症潜在的治疗点.
- CD44表达分析有助于患者分层和治疗决策.
- 向CD44显示未来临床应用的希望.
相关概念视频
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...


